Business expansion
Bassin Parisien; Centre; Eure-et-Loir
Location of affected unit(s)
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture of pharmaceutical preparations

100 jobs
Number of planned job creations
Job creation
Announcement Date
5 September 2018
Employment effect (start)
15 September 2018
Foreseen end date
31 December 2021


Novo Nordisk, the Danish pharmaceutical group that is the world leader in the treatment of diabetes, has announced the recruitment of 100 employees for its site at Chartres (Eure-et-Loir). After several waves of hiring the last years (250 job creations in 2016, 150 job creations in 2013), the site opens a new recruitment campaign of 100 positions and announces a project to expand the plant. Novo Nordisk already has 1,200 employees on site. A first hiring period is planned for half of the new employees to recruit operators, regulators, line drivers and technicians. It will last until the end of the year.

A second phase of hiring focuses air handling engineers, process engineers, building engineers and computer scientists. It will follow the construction of two new production lines by March 2019. The hiring will concern the department of Eure-et-Loire, but will be extended to the region Center-Loire Valley and the Parisian region, and then to the whole France. Novo Mordisk will work closely with the public employment service (Pôle Emploi) and will broadcast ads on internal networks and social networks.



Eurofound (2018), Novo Nordisk Production, Business expansion in France, factsheet number 95478, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/95478.